Mar 2, 2023 7:30 am EST BioRestorative Therapies Receives Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program
Feb 10, 2023 8:45 am EST BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
Feb 10, 2023 8:45 am EST BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
Feb 8, 2023 9:00 am EST BioRestorative Therapies Announces Notice of Allowance by the European Patent Office for Patent Related to its ThermoStem® Program
Feb 3, 2023 9:25 am EST BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
Jan 26, 2023 8:30 am EST 2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
Dec 6, 2022 7:00 am EST BioRestorative Therapies Announces SBIR Phase I Grant to Explore the Therapeutic Effects of ThermoStem® Targeting Polycystic Ovary Syndrome as an Indication
Dec 5, 2022 7:00 am EST BioRestorative Therapies Enters Agreement with Regenexx, Granting BRTX Exclusive License Rights for Intellectual Property Related to the Development and Commercialization of its BRTX-100® Disc Program to Treat Chronic Lumbar Disc Disease
Nov 29, 2022 11:20 am EST BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022
Nov 16, 2022 8:56 am EST BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022